#news #biotech Biohaven flunks Alzheimer’s phase 2/3, touts failed subgroup as sign of efficacy

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Biohaven flunks Alzheimer’s phase 2/3, touts failed subgroup as sign of efficacy .Biohaven flunks Alzheimer’s phase 2/3, touts failed subgroup as sign of efficacy
ntaylor
Tue, 01/19/2021 – 06:20

from FierceBiotech: Biotech https://ift.tt/35U57dU